Physician profile
Jason E Lee
NPI 1144459728
$5,419.27
in general payments reported to CMS, 2019-2025
27 companies · $1,694 in 2025
The $1,694 reported for 2025 was more than what 80% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $924 · 2020: $183 · 2021: $469 · 2022: $1,000 · 2023: $1,033 · 2024: $117 · 2025: $1,694.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,551 · Travel and Lodging: $1,293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,550.52 |
| Travel and Lodging | $1,293.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,547.59 | 2019-2025 | Grafix Pl, Stravix Pl, Stravix |
| Mid-Atlantic Surgical Systems, LLC | $962.23 | 2019-2025 | |
| Arthrex, INC. | $696.40 | 2025 | |
| Organogenesis INC. | $459.47 | 2019-2022 | |
| Kerecis Limited | $308.57 | 2019-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Misonix INC | $150.24 | 2021 | |
| Bioventus LLC | $147.10 | 2019-2022 | |
| Orthofix Medical, INC. | $135.25 | 2020-2023 | Trinity Elite, Truelok System, Truelok |
| Davol INC. | $120.16 | 2022 | |
| Averitas Pharma INC. | $119.01 | 2023-2024 | Qutenza |
| Abbott Laboratories | $102.55 | 2019-2022 | |
| Axogen | $100.28 | 2019 | |
| Flower Orthopedics Coporation | $93.04 | 2022-2023 | |
| Treace Medical Concepts, INC. | $78.15 | 2023 | |
| Musculoskeletal Transplant Foundation INC. | $74.88 | 2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $60.18 | 2019-2020 | |
| Kci USA, INC. | $57.28 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $41.49 | 2019 | |
| Novo Nordisk INC | $29.33 | 2019-2021 | |
| Polynovo North America LLC | $25.62 | 2022 | |
| Endo Pharmaceuticals INC. | $18.90 | 2019 | |
| Biotissue Holdings INC. | $18.36 | 2021 | |
| Paratek Pharmaceuticals, INC. | $17.04 | 2022 | |
| Grifols USA, LLC | $15.50 | 2020 | |
| Stryker Corporation | $14.04 | 2020 | |
| Integra Lifesciences Corporation | $13.95 | 2019 | |
| Cook Medical LLC | $12.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.